Global Cord Blood Corp
DelistedCIK 1467808fmd_1FP8G69VEEZANYVEJHT4NRPXSPServices · Services-Misc Health & Allied Services, NECTemplate: Standard
Coverage: Apr 01, 2009 to Mar 31, 2022, 30 periods
Latest annual · FY2022
Millions- Total revenues
- 1,243
- Gross profit
- 1,060
- Operating income
- 609
- Net income
- 501
- Free cash flow
- 594
Latest quarter · Q2 FY2022
Millions- Total revenues
- 314
- Gross profit
- 267
- Operating income
- 160
- Net income
- 126
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2019 to FY2022
- +8.0%
- Revenue, 5 yearsFY2017 to FY2022
- +10.3%
- Net income, 5 yearsFY2017 to FY2022
- +31.8%
Global Cord Blood Corp financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | CN¥1.2 billion | CN¥1.2 billion | +7.2% | 20-F 2022-08-16 · proof |
| Gross profit | CN¥1.1 billion | CN¥980.7 million | +8.1% | 20-F 2022-08-16 · proof |
| Operating income | CN¥608.9 million | CN¥544.9 million | +11.7% | 20-F 2022-08-16 · proof |
| Net income | CN¥501.1 million | CN¥508.2 million | -1.4% | 20-F 2022-08-16 · proof |
| Cash from operating activities | CN¥613.6 million | CN¥630.7 million | -2.7% | 20-F 2022-08-16 · proof |
| Free cash flow | CN¥593.8 million | CN¥609.8 million | -2.6% | 20-F 2022-08-16 · proof |
| Total assets | CN¥8.5 billion | CN¥7.9 billion | +7.9% | 20-F 2022-08-16 · proof |
| Total liabilities | CN¥3.6 billion | CN¥3.5 billion | +3.7% | 20-F 2022-08-16 · proof |
| Cash and cash equivalents | CN¥6.7 billion | CN¥6.1 billion | +9.6% | 20-F 2022-08-16 · proof |
- What was Global Cord Blood Corp's revenue in fiscal 2022?
- Global Cord Blood Corp reported revenue of CN¥1.2 billion for fiscal 2022 (the year ended Mar 31, 2022), against CN¥1.2 billion the year before (+7.2%). Source: the 20-F filed with the SEC on Aug 16, 2022. SEC
- What was Global Cord Blood Corp's gross profit in fiscal 2022?
- Global Cord Blood Corp reported gross profit of CN¥1.1 billion for fiscal 2022 (the year ended Mar 31, 2022), against CN¥980.7 million the year before (+8.1%). Source: the 20-F filed with the SEC on Aug 16, 2022. SEC
- What was Global Cord Blood Corp's operating income in fiscal 2022?
- Global Cord Blood Corp reported operating income of CN¥608.9 million for fiscal 2022 (the year ended Mar 31, 2022), against CN¥544.9 million the year before (+11.7%). Source: the 20-F filed with the SEC on Aug 16, 2022. SEC
- What was Global Cord Blood Corp's net income in fiscal 2022?
- Global Cord Blood Corp reported net income of CN¥501.1 million for fiscal 2022 (the year ended Mar 31, 2022), against CN¥508.2 million the year before (-1.4%). Source: the 20-F filed with the SEC on Aug 16, 2022. SEC
- What was Global Cord Blood Corp's cash from operating activities in fiscal 2022?
- Global Cord Blood Corp reported cash from operating activities of CN¥613.6 million for fiscal 2022 (the year ended Mar 31, 2022), against CN¥630.7 million the year before (-2.7%). Source: the 20-F filed with the SEC on Aug 16, 2022. SEC
- What was Global Cord Blood Corp's free cash flow in fiscal 2022?
- Global Cord Blood Corp reported free cash flow of CN¥593.8 million for fiscal 2022 (the year ended Mar 31, 2022), against CN¥609.8 million the year before (-2.6%). Source: the 20-F filed with the SEC on Aug 16, 2022. SEC
- What are Global Cord Blood Corp's total assets?
- As of Mar 31, 2022, Global Cord Blood Corp reported total assets of CN¥8.5 billion, against CN¥7.9 billion a year earlier (+7.9%). Source: the 20-F filed with the SEC on Aug 16, 2022. SEC
- What are Global Cord Blood Corp's total liabilities?
- As of Mar 31, 2022, Global Cord Blood Corp reported total liabilities of CN¥3.6 billion, against CN¥3.5 billion a year earlier (+3.7%). Source: the 20-F filed with the SEC on Aug 16, 2022. SEC
- What are Global Cord Blood Corp's cash and cash equivalents?
- As of Mar 31, 2022, Global Cord Blood Corp reported cash and cash equivalents of CN¥6.7 billion, against CN¥6.1 billion a year earlier (+9.6%). Source: the 20-F filed with the SEC on Aug 16, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1467808&period_type=annual&limit=5"Information only, not investment advice.